900 related articles for article (PubMed ID: 17680535)
1. [The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
Zhao C; Wang YY; Xiao ZX; Wang YP; Zhang QY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):428-31. PubMed ID: 17680535
[TBL] [Abstract][Full Text] [Related]
2. Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals.
Yamada Y; Fujisawa M; Ando F; Niino N; Tanaka M; Shimokata H
J Hum Genet; 2002; 47(5):243-8. PubMed ID: 12032592
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker.
Zhu S; Liu Y; Wang L; Meng QH
Nephrol Dial Transplant; 2008 Sep; 23(9):2841-6. PubMed ID: 18390891
[TBL] [Abstract][Full Text] [Related]
4. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.
Brezzi B; Del Prete D; Lupo A; Magistroni R; Gomez-Lira M; Bernich P; Anglani F; Mezzabotta F; Turco A; Furci L; Ceol M; Antonucci F; Abaterusso C; Bonfante L; D'Angelo A; Albertazzi A; Gambaro G
J Nephrol; 2009; 22(6):747-59. PubMed ID: 19967654
[TBL] [Abstract][Full Text] [Related]
5. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients.
Altun B; Yilmaz R; Kahraman S; Gençtoy G; Arici M; Onalan O; Oto A; Hayran M; Bakkaloğlu M; Yasavul U; Turgan C
Transpl Int; 2005 Jun; 18(6):681-9. PubMed ID: 15910294
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage.
Argano C; Duro G; Corrao S; Di Chiara T; Nuzzo D; Colomba D; Scaglione R; Licata G
Blood Press; 2008; 17(4):220-6. PubMed ID: 18821144
[TBL] [Abstract][Full Text] [Related]
7. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
[TBL] [Abstract][Full Text] [Related]
8. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
[TBL] [Abstract][Full Text] [Related]
9. [Association of alpha-adducin and angiotensin converting enzyme gene polymorphisms with salt-sensitive hypertension and early renal injury].
Lu LH; Chen H; Yu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):132-5. PubMed ID: 18393230
[TBL] [Abstract][Full Text] [Related]
10. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the TGF-beta1 gene -509C/T polymorphism and tubulointerstitial damage resulting from primary nephrotic syndrome.
Li Y; Liu FY; Peng YM; Li J; Sun L; Chen X; Duan SB; Ling GH; Guo N; Liu YH
Ren Fail; 2010 May; 32(4):420-7. PubMed ID: 20446778
[TBL] [Abstract][Full Text] [Related]
12. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between TGF-beta-1 genotypes and microalbuminuria in essential hypertensive men.
Dell'Omo G; Penno G; Pucci L; Lucchesi D; Del Prato S; Pedrinelli R
Nephrol Dial Transplant; 2009 Jun; 24(6):1864-9. PubMed ID: 19176688
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
[TBL] [Abstract][Full Text] [Related]
15. [Association between transforming growth factor beta-1 gene polymorphism and chronic allograft nephropathy].
Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; DU CF; Wang YB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):535-7. PubMed ID: 17545053
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β1-gene polymorphism in the development of kidney disease after liver transplantation.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Bahra M; Neuhaus P; Schmitz V
Transplantation; 2012 Mar; 93(5):555-60. PubMed ID: 22366990
[TBL] [Abstract][Full Text] [Related]
18. Comparing antihypertensive effect and plasma ciclosporin concentration between amlodipine and valsartan regimens in hypertensive renal transplant patients receiving ciclosporin therapy.
Cai J; Huang Z; Yang G; Cheng K; Ye Q; Ming Y; Zuo X; Zhou P; Yuan H
Am J Cardiovasc Drugs; 2011 Dec; 11(6):401-9. PubMed ID: 22149319
[TBL] [Abstract][Full Text] [Related]
19. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women.
Yamada Y; Miyauchi A; Goto J; Takagi Y; Okuizumi H; Kanematsu M; Hase M; Takai H; Harada A; Ikeda K
J Bone Miner Res; 1998 Oct; 13(10):1569-76. PubMed ID: 9783545
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
